secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bioventus Inc. (BVS)
CIK:        0001665988
Form:       8-K
Filed at:   2025-06-04T23:59:59+00:00
Accession:  0001665988-25-000010
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Bioventus shareholders elect all six director nominees, ratify Grant Thornton as auditor for FY2025
--------------------------------------------------------------------------------

- All six Class I director nominees elected with 58M to 64.9M votes; broker non-votes 8.59M each.
- Ratification of Grant Thornton as auditor: 73.46M for, 149k against, 11k abstain.
- Turnout: 73.62M shares (89.76% of outstanding) present at June 3, 2025 annual meeting.
- Directors elected until 2026 annual meeting: Claypoole, Cowdy, McMurry-Heath, Neels, Nohra, Sutter.
- No other business voted on; all proposals passed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1665988/000166598825000010/0001665988-25-000010-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1665988/000166598825000010/bvs-20250603.htm
  HTML page:      https://secwatch.observer/filing/0001665988-25-000010

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer